NPI-32101

N/A

Report date: 2025/01/26 16:45:02
NME

Base Information

Drug NameNPI-32101
Drug Alias Namenanocrystalline silver (Nucryst)nanocrystalline silver (Smith & Nephew)NPI-32101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInflammationPsoriasisAcne Vulgaris +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlmalco Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSmith & Nephew Ltd
Inactive CompaniesAlmalco Ltd
Active IndicationsInflammation
Inactive IndicationsPsoriasisAcne VulgarisDermatitis, Atopic +[6] 

Other Information

ATC CodeN/A
Related LinksN/A